Literature DB >> 19845778

Development and validation of a new questionnaire for the assessment of subjective physical performance in adult patients with haemophilia--the HEP-Test-Q.

S von Mackensen1, D Czepa, M Herbsleb, T Hilberg.   

Abstract

Specific research studies for the investigation of physical performance in haemophilic patients are rare. However, these instruments become increasingly more important to evaluate therapeutic treatments. Within the frame of the Haemophilia & Exercise Project (HEP), a new questionnaire, namely HEP-Test-Q, has been developed for the assessment of subjective physical performance in haemophilic adults. In this article, the development and validation of the HEP-Test-Q is described. The development consisted of different phases including item collection, pilot testing and field testing. The preliminary version was pilot-tested in 24 German HEP-participants. Following evaluation and preliminary psychometric analysis, the HEP-Test-Q was revised. The final version consists of 25 items pertaining to the domains 'mobility', 'strength & coordination', 'endurance' and 'body perception', which was administered to 43 German haemophilic patients (43.8 +/- 11.2 years). Psychometric analysis included reliability and validity testing. Convergent validity was tested correlating the HEP-Test-Q with SF-36, Haem-A-QoL, HAL and the Orthopaedic Joint Score. Discriminant validity tested different clinical subgroups. Patients accepted the questionnaire and found it easy to fill in. Psychometric testing revealed good values for reliability in terms of internal consistency (Cronbach's alpha = 0.96) and test-retest reliability (r = 0.90) as well as for convergent validity correlating highly with Haem-A-QoL, HAL and SF-36. Discriminant validity testing showed significant differences for age, hepatitis A and hepatitis B and the number of target joints. HEP-Test-Q is a short and well-accepted questionnaire, assessing subjective physical performance of haemophiliacs, which might be combined with objective assessments to reveal aspects, which cannot be measured objectively, such as body perception.

Entities:  

Mesh:

Year:  2009        PMID: 19845778     DOI: 10.1111/j.1365-2516.2009.02112.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  5 in total

1.  Physical activity improved by adherence to prophylaxis in an Italian population of children, adolescents and adults with severe haemophilia A: the SHAPE Study.

Authors:  Ezio Zanon; Annarita Tagliaferri; Samantha Pasca; Cosimo P Ettorre; Lucia D Notarangelo; Chiara Biasioli; Anna B Aru; Marta Milan; Silvia Linari; Angiola Rocino; Fabio Gagliano; Giovanni Di Minno; Gabriella Gamba; Rita C Santoro; Piercarla Schinco; Marco Marietta; Axel Seuser; Sylvia von Mackensen
Journal:  Blood Transfus       Date:  2019-06-05       Impact factor: 3.443

2.  Issues in the measurement of quality of life in hemophilia.

Authors:  Brian M Feldman
Journal:  Rev Bras Hematol Hemoter       Date:  2013

3.  Content comparison of haemophilia specific patient-rated outcome measures with the international classification of functioning, disability and health (ICF, ICF-CY).

Authors:  Silvia Riva; Monika Bullinger; Edda Amann; Sylvia von Mackensen
Journal:  Health Qual Life Outcomes       Date:  2010-11-25       Impact factor: 3.186

4.  Sports participation and physical activity in adult Dutch and Swedish patients with severe haemophilia: A comparison between intermediate- and high-dose prophylaxis.

Authors:  Olav Versloot; Erik Berntorp; Pia Petrini; Rolf Ljung; Jan Astermark; Margareta Holmström; Piet de Kleijn; Kathelijn Fischer
Journal:  Haemophilia       Date:  2019-01-28       Impact factor: 4.287

5.  Generic PROMIS item banks in adults with hemophilia for patient-reported outcome assessment: Feasibility, measurement properties, and relevance.

Authors:  Isolde A R Kuijlaars; Lorynn Teela; Lize F D van Vulpen; Merel A Timmer; Michiel Coppens; Samantha C Gouw; Marjolein Peters; Marieke J H A Kruip; Marjon H Cnossen; Jelmer J Muis; Evelien S van Hoorn; Lotte Haverman; Kathelijn Fischer
Journal:  Res Pract Thromb Haemost       Date:  2021-11-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.